Abstract
Management decisions for complex cases should be made on the basis of multidisciplinary consensus in order to ensure that the optimal treatment decisions are made within a setting of increasing case complexity coupled with an expanding range of treatment options, many of which are very expensive. An NHS England commissioning for quality and innovation (CQUIN) was introduced for autoimmune rheumatic diseases in 2016. The aim of this proposal was to develop and implement an innovative software system to capture data on clinical caseload including complex disease status assessment using validated measures so that we could evaluate each patient and use a …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
